Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-08-16 Sale |
2021-08-18 7:00 pm |
NEKTAR THERAPEUTICS | NKTR | Thomsen Jillian B. SVP & Chief Accounting Officer |
13,339 | $13.83 | $184,478 | 137,822 (Direct) |
View |
| 2021-08-16 Sale |
2021-08-18 6:59 pm |
NEKTAR THERAPEUTICS | NKTR | NORTHCOTT JOHN SVP & Chief Commercial Officer |
6,192 | $13.83 | $85,635 | 200,915 (Direct) |
View |
| 2021-08-16 Sale |
2021-08-18 6:58 pm |
NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO |
10,867 | $13.76 | $149,481 | 240,231 (Direct) |
View |
| 2021-07-20 Sale |
2021-07-22 7:13 pm |
NEKTAR THERAPEUTICS | NKTR | CHESS ROBERT Director |
5,721 | $16.81 | $96,148 | 339,116 (Direct) |
View |
| 2021-05-17 Sale |
2021-05-19 7:08 pm |
NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer |
31,111 | $18.3 | $569,331 | 235,065 (Direct) |
View |
| 2021-05-17 Sale |
2021-05-19 7:07 pm |
NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew SVP & General Counsel |
1,917 | $18.3 | $35,081 | 74,810 (Direct) |
View |
| 2021-05-17 Sale |
2021-05-19 7:06 pm |
NEKTAR THERAPEUTICS | NKTR | Thomsen Jillian B. SVP & Chief Accounting Officer |
13,391 | $18.3 | $245,055 | 151,161 (Direct) |
View |
| 2021-05-17 Sale |
2021-05-19 7:05 pm |
NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W President & CEO |
11,560 | $18.3 | $211,548 | 436,048 (Indirect Direct) |
View |
| 2021-05-17 Sale |
2021-05-19 7:04 pm |
NEKTAR THERAPEUTICS | NKTR | NORTHCOTT JOHN SVP & Chief Commercial Officer |
6,085 | $18.3 | $111,356 | 207,107 (Direct) |
View |
| 2021-05-17 Sale |
2021-05-19 7:04 pm |
NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO |
7,898 | $18.3 | $144,533 | 251,098 (Direct) |
View |
| 2021-05-12 Sale |
2021-05-14 6:05 pm |
NEKTAR THERAPEUTICS | NKTR | CHESS ROBERT Director |
8,000 | $19.34 | $154,720 | 304,573 (Direct) |
View |
| 2021-04-14 Sale |
2021-04-16 6:02 pm |
NEKTAR THERAPEUTICS | NKTR | CHESS ROBERT Director |
8,000 | $18.98 | $151,840 | 312,573 (Direct) |
View |
| 2021-02-16 Sale |
2021-02-18 7:07 pm |
NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer |
24,141 | $22.37 | $540,034 | 266,176 (Direct) |
View |
| 2021-02-16 Sale |
2021-02-18 7:06 pm |
NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew SVP & General Counsel |
2,173 | $22.37 | $48,610 | 76,727 (Direct) |
View |
| 2021-02-16 Sale |
2021-02-18 7:05 pm |
NEKTAR THERAPEUTICS | NKTR | Thomsen Jillian B. SVP & Chief Accounting Officer |
11,705 | $22.37 | $261,841 | 164,552 (Direct) |
View |
| 2021-02-16 Sale |
2021-02-18 7:04 pm |
NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W President & CEO |
11,495 | $22.37 | $257,143 | 447,608 (Indirect Direct) |
View |
| 2021-02-16 Sale |
2021-02-18 7:03 pm |
NEKTAR THERAPEUTICS | NKTR | NORTHCOTT JOHN SVP & Chief Commercial Officer |
15,358 | $22.37 | $343,558 | 213,192 (Direct) |
View |
| 2021-02-16 Sale |
2021-02-18 7:03 pm |
NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO |
7,977 | $22.37 | $178,445 | 258,996 (Direct) |
View |
| 2021-02-03 Sale |
2021-02-04 8:44 pm |
NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew SVP & General Counsel |
5,344 | $19.45 | $103,941 | 78,900 (Direct) |
View |
| 2021-02-02 Sale |
2021-02-04 8:43 pm |
NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W President & CEO |
450,000 | $19.93 | $8,966,931 | 684,103 (Indirect Direct) |
View |
| 2021-02-02 Sale |
2021-02-04 8:42 pm |
NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO |
150,000 | $19.86 | $2,979,629 | 341,973 (Direct) |
View |
| 2021-01-28 Sale |
2021-01-29 6:10 pm |
NEKTAR THERAPEUTICS | NKTR | Thomsen Jillian B. SVP & Chief Accounting Officer |
75,000 | $18.62 | $1,396,500 | 176,257 (Direct) |
View |
| 2020-12-15 Sale |
2020-12-17 6:08 pm |
NEKTAR THERAPEUTICS | NKTR | Myriam Curet Director |
1,560 | $17.82 | $27,799 | 19,240 (Direct) |
View |
| 2020-11-23 Sale |
2020-11-25 6:09 pm |
NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer |
16,380 | $16.4 | $268,632 | 250,317 (Direct) |
View |
| 2020-11-16 Sale |
2020-11-18 7:08 pm |
NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer |
29,618 | $16.93 | $501,433 | 266,697 (Direct) |
View |
| 2020-11-16 Sale |
2020-11-18 7:07 pm |
NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew SVP & General Counsel |
1,539 | $16.93 | $26,055 | 49,850 (Direct) |
View |
| 2020-11-16 Sale |
2020-11-18 7:05 pm |
NEKTAR THERAPEUTICS | NKTR | Thomsen Jillian B. SVP & Chief Accounting Officer |
11,976 | $16.93 | $202,754 | 159,757 (Direct) |
View |
| 2020-11-16 Sale |
2020-11-18 7:04 pm |
NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W President & CEO |
11,975 | $16.93 | $202,737 | 352,453 (Indirect Direct) |
View |
| 2020-11-16 Sale |
2020-11-18 7:03 pm |
NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO |
8,276 | $16.93 | $140,113 | 226,973 (Direct) |
View |
| 2020-09-28 Sale |
2020-09-30 7:03 pm |
NEKTAR THERAPEUTICS | NKTR | Ajer Jeffrey Robert Director |
3,250 | $17.25 | $56,063 | 25,975 (Direct) |
View |
| 2020-09-25 Sale |
2020-09-25 8:16 pm |
NEKTAR THERAPEUTICS | NKTR | CHESS ROBERT Director |
5,500 | $17.75 | $97,625 | 280,573 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-07-20 Exercise |
2021-07-22 7:13 pm |
N/A N/A |
NEKTAR THERAPEUTICS | NKTR | CHESS ROBERT Director |
5,721 | $13.8 | 339,116 (Direct) |
View |
| 2021-07-20 Exercise |
2021-07-22 7:13 pm |
2014-09-30 2021-09-18 |
NEKTAR THERAPEUTICS | NKTR | CHESS ROBERT Director |
5,721 | $0 | 339,116 (Direct) |
View |
| 2021-05-12 Exercise |
2021-05-14 6:05 pm |
N/A N/A |
NEKTAR THERAPEUTICS | NKTR | CHESS ROBERT Director |
8,000 | $13.8 | 304,573 (Direct) |
View |
| 2021-05-12 Exercise |
2021-05-14 6:05 pm |
2014-09-30 2021-09-18 |
NEKTAR THERAPEUTICS | NKTR | CHESS ROBERT Director |
8,000 | $0 | 304,573 (Direct) |
View |
| 2021-04-14 Exercise |
2021-04-16 6:02 pm |
N/A N/A |
NEKTAR THERAPEUTICS | NKTR | CHESS ROBERT Director |
8,000 | $13.8 | 312,573 (Direct) |
View |
| 2021-04-14 Exercise |
2021-04-16 6:02 pm |
2014-09-30 2021-09-18 |
NEKTAR THERAPEUTICS | NKTR | CHESS ROBERT Director |
8,000 | $0 | 312,573 (Direct) |
View |
| 2021-02-03 Exercise |
2021-02-04 8:44 pm |
N/A N/A |
NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew SVP & General Counsel |
5,344 | $8.8 | 78,900 (Direct) |
View |
| 2021-02-03 Exercise |
2021-02-04 8:44 pm |
2017-02-06 2021-02-05 |
NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew SVP & General Counsel |
5,344 | $0 | 78,900 (Direct) |
View |
| 2021-02-02 Exercise |
2021-02-04 8:43 pm |
N/A N/A |
NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W President & CEO |
375,000 | $8.8 | 684,103 (Direct) |
View |
| 2021-02-02 Exercise |
2021-02-04 8:43 pm |
2017-02-06 2021-02-05 |
NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W President & CEO |
450,000 | $0 | 684,103 (Direct) |
View |
| 2021-02-02 Exercise |
2021-02-04 8:42 pm |
N/A N/A |
NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO |
125,000 | $8.8 | 341,973 (Direct) |
View |
| 2021-02-02 Exercise |
2021-02-04 8:42 pm |
2017-02-06 2021-02-05 |
NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO |
150,000 | $0 | 341,973 (Direct) |
View |
| 2021-01-28 Exercise |
2021-01-29 6:10 pm |
N/A N/A |
NEKTAR THERAPEUTICS | NKTR | Thomsen Jillian B. SVP & Chief Accounting Officer |
37,500 | $8.8 | 176,257 (Direct) |
View |
| 2021-01-28 Exercise |
2021-01-29 6:10 pm |
2017-02-06 2021-02-05 |
NEKTAR THERAPEUTICS | NKTR | Thomsen Jillian B. SVP & Chief Accounting Officer |
75,000 | $0 | 176,257 (Direct) |
View |
| 2021-01-05 Exercise |
2021-01-05 5:09 pm |
N/A N/A |
NEKTAR THERAPEUTICS | NKTR | GREER R SCOTT Director |
40,000 | $13.8 | 225,674 (Direct) |
View |
| 2021-01-05 Exercise |
2021-01-05 5:09 pm |
2014-09-30 2021-09-18 |
NEKTAR THERAPEUTICS | NKTR | GREER R SCOTT Director |
40,000 | $0 | 225,674 (Direct) |
View |
| 2020-12-30 Gift |
2021-01-04 6:06 pm |
N/A N/A |
NEKTAR THERAPEUTICS | NKTR | WHITFIELD ROY A Director |
51,500 | $0 | 257,350 (Direct) |
View |
| 2020-12-18 Option Award |
2020-12-22 6:53 pm |
N/A 2028-12-17 |
NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer |
111,500 | $0 | 361,817 (Direct) |
View |
| 2020-12-18 Option Award |
2020-12-22 6:52 pm |
N/A 2028-12-17 |
NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew SVP & General Counsel |
79,550 | $0 | 129,900 (Direct) |
View |
| 2020-12-18 Option Award |
2020-12-22 6:51 pm |
N/A 2028-12-17 |
NEKTAR THERAPEUTICS | NKTR | Thomsen Jillian B. SVP & Chief Accounting Officer |
44,600 | $0 | 204,857 (Direct) |
View |
| 2020-12-18 Option Award |
2020-12-22 6:50 pm |
N/A 2028-12-17 |
NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W President & CEO |
297,300 | $0 | 649,753 (Direct) |
View |
| 2020-12-18 Option Award |
2020-12-22 6:49 pm |
N/A 2028-12-17 |
NEKTAR THERAPEUTICS | NKTR | NORTHCOTT JOHN SVP & Chief Commercial Officer |
79,550 | $0 | 279,550 (Direct) |
View |
| 2020-12-18 Option Award |
2020-12-22 6:48 pm |
N/A 2028-12-17 |
NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO |
111,500 | $0 | 338,473 (Direct) |
View |
| 2020-09-22 Option Award(A) |
2020-09-25 8:15 pm |
N/A 2028-09-21 |
NEKTAR THERAPEUTICS | NKTR | WHITFIELD ROY A Director |
27,300 | $0 | 275,550 (Direct) |
View |